Erratum: A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (Gynecol Oncol 127 (2012) (538-543))

Robert L. Coleman; Michael W. Sill; Heather A. Lankes; Amanda Nickles Fader; Neil J. Finkler; James S. Hoffman; Peter G. Rose; Gregory P. Sutton; Charles W. Drescher; D. Scott McMeekin; Wei Hu; Michael Deavers; Andrew K. Godwin; R. Katherine Alpaugh; Anil K. Sood

doi:10.1016/j.ygyno.2013.04.007

Erratum: A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (Gynecol Oncol 127 (2012) (538-543))

Robert L. Coleman, Michael W. Sill, Heather A. Lankes, Amanda Nickles Fader, Neil J. Finkler, James S. Hoffman, Peter G. Rose, Gregory P. Sutton, Charles W. Drescher, D. Scott McMeekin, Wei Hu, Michael Deavers, Andrew K. Godwin, R. Katherine Alpaugh, Anil K. Sood

Department of Pathology & Genomic Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	252-253
Number of pages	2
Journal	Gynecologic oncology
Volume	130
Issue number	1
DOIs	https://doi.org/10.1016/j.ygyno.2013.04.007
State	Published - Jul 2013

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/j.ygyno.2013.04.007

Cite this

Coleman, R. L., Sill, M. W., Lankes, H. A., Fader, A. N., Finkler, N. J., Hoffman, J. S., Rose, P. G., Sutton, G. P., Drescher, C. W., McMeekin, D. S., Hu, W., Deavers, M., Godwin, A. K., Alpaugh, R. K., & Sood, A. K. (2013). Erratum: A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (Gynecol Oncol 127 (2012) (538-543)). Gynecologic oncology, 130(1), 252-253. https://doi.org/10.1016/j.ygyno.2013.04.007

Erratum: A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (Gynecol Oncol 127 (2012) (538-543)). / Coleman, Robert L.; Sill, Michael W.; Lankes, Heather A. et al.
In: Gynecologic oncology, Vol. 130, No. 1, 07.2013, p. 252-253.

Research output: Contribution to journal › Comment/debate › peer-review

Coleman, RL, Sill, MW, Lankes, HA, Fader, AN, Finkler, NJ, Hoffman, JS, Rose, PG, Sutton, GP, Drescher, CW, McMeekin, DS, Hu, W, Deavers, M, Godwin, AK, Alpaugh, RK & Sood, AK 2013, 'Erratum: A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (Gynecol Oncol 127 (2012) (538-543))', Gynecologic oncology, vol. 130, no. 1, pp. 252-253. https://doi.org/10.1016/j.ygyno.2013.04.007

@article{5308b5a3f52c4ab98db7e4c341c2e1a4,

title = "Erratum: A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (Gynecol Oncol 127 (2012) (538-543))",

author = "Coleman, {Robert L.} and Sill, {Michael W.} and Lankes, {Heather A.} and Fader, {Amanda Nickles} and Finkler, {Neil J.} and Hoffman, {James S.} and Rose, {Peter G.} and Sutton, {Gregory P.} and Drescher, {Charles W.} and McMeekin, {D. Scott} and Wei Hu and Michael Deavers and Godwin, {Andrew K.} and Alpaugh, {R. Katherine} and Sood, {Anil K.}",

year = "2013",

month = jul,

doi = "10.1016/j.ygyno.2013.04.007",

language = "English (US)",

volume = "130",

pages = "252--253",

journal = "Gynecologic oncology",

issn = "0090-8258",

publisher = "Academic Press",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (Gynecol Oncol 127 (2012) (538-543))

AU - Coleman, Robert L.

AU - Sill, Michael W.

AU - Lankes, Heather A.

AU - Fader, Amanda Nickles

AU - Finkler, Neil J.

AU - Hoffman, James S.

AU - Rose, Peter G.

AU - Sutton, Gregory P.

AU - Drescher, Charles W.

AU - McMeekin, D. Scott

AU - Hu, Wei

AU - Deavers, Michael

AU - Godwin, Andrew K.

AU - Alpaugh, R. Katherine

AU - Sood, Anil K.

PY - 2013/7

Y1 - 2013/7

UR - http://www.scopus.com/inward/record.url?scp=84879116959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879116959&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2013.04.007

DO - 10.1016/j.ygyno.2013.04.007

M3 - Comment/debate

AN - SCOPUS:84879116959

SN - 0090-8258

VL - 130

SP - 252

EP - 253

JO - Gynecologic oncology

JF - Gynecologic oncology

IS - 1

ER -

Erratum: A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (Gynecol Oncol 127 (2012) (538-543))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this